NEW YORK, Jan. 8, 2016 /PRNewswire/ -- The article
excerpt below from PM360 Magazine, written by Richie Etwaru, chief digital officer, IMS Health
(NYSE:IMS), introduces the concept of Orchestrated Customer
Engagement to the life sciences industry---a concept that combines
the automation of multichannel marketing with the human touch of
traditional sales and the power of next-generation
technology.
ARTICLE EXCERPT:
Many life sciences companies are just beginning to
formulate or implement multichannel or omnichannel marketing
strategies, automating processes that will let them communicate
more effectively with healthcare professionals across a number of
different channels. Even so, many companies are already thinking
about the next big step in the evolution of pharmaceutical sales
and marketing: Orchestrated Customer Engagement (OCE).
With OCE, sales, marketing and information technology are
closely aligned. The three teams work together to provide customers
with relevant and timely information, resources and experiences.
The OCE approach to customer engagement is designed to improve the
relationship between life sciences companies and their customers,
and to increase efficiency across all communication channels and
stakeholders while boosting ROI.
To view the entire article as it appears on PM360
Magazine click here:
https://www.pm360online.com/how-to-achieve-orchestrated-customer-engagement/
About IMS Health
IMS Health (NYSE:IMS) is a leading global information and
technology services company providing clients in the healthcare
industry with end-to-end solutions to measure and improve their
performance. Our 7,500 services experts connect configurable SaaS
applications to 10+ petabytes of complex healthcare data in
the IMS One™ cloud platform, delivering unique insights
into diseases, treatments, costs and outcomes. The company's 15,000
employees blend global consistency and local market knowledge
across 100 countries to help clients run their operations more
efficiently. Customers include pharmaceutical, consumer health and
medical device manufacturers and distributors, providers, payers,
government agencies, policymakers, researchers and the financial
community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available
at www.imshealth.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/how-to-achieve-orchestrated-customer-engagement-300201447.html
SOURCE IMS Health